Moleculin Biotech(DE:MOL)
€7.580.00 (0.00%)
DE:MOL
Moleculin Biotech earnings date
€7.58
At close:0.00 (0.00%)
Moleculin Biotech (MOL) Q4 2021 Earnings Report
3 Followers
DE:MOL Q4 2021 EPS Results
- Actual EPS
- -EUR 60.44
- Consensus EPS
- -EUR 65.47
- Beat/Miss
- Beat by +EUR 5.04
- One Year Ago EPS
- -EUR 80.58
DE:MOL Q4 2021 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2021
- Date
- 03/25/2022
- Time
- Before Open
- Conference Call
- Friday, March 25, 2022
DE:MOL Upcoming Earnings
Moleculin Biotech's next earnings date is estimated for March 19, 2027, based on past reporting schedules.
Q4 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:MOL Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 19, 2027 | 2026 (Q4) | ―- | 2.34 | ― | ― |
| Aug 14, 2026 | 2026 (Q2) | -27.82-25.07 | -219.36 | 88.57% (+194.29) | |
| May 15, 2026 | 2026 (Q1) | -41.78-63.39 | -308.9 | 79.48% (+245.50) | |
| Mar 19, 2026 | 2025 (Q4) | -109.4746.74 | 111.92 | -58.24% (-65.18) | |
| Nov 17, 2025 | 2025 (Q3) | -5.89-15.23 | -63.79 | 76.12% (+48.56) | |
| Aug 13, 2025 | 2025 (Q2) | -192.50-219.36 | -761.05 | 71.18% (+541.69) | |
| May 14, 2025 | 2025 (Q1) | -248.46-308.90 | -904.3 | 65.84% (+595.41) | |
| Mar 24, 2025 | 2024 (Q4) | -574.52111.92 | -2247.33 | 104.98% (+2359.25) | |
| Nov 11, 2024 | 2024 (Q3) | -1092.33-1275.87 | -1275.87 | 0.00% (+0.00) | |
| Aug 14, 2024 | 2024 (Q2) | -1123.66-761.05 | -1343.02 | 43.33% (+581.98) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
